My FY25 opex-to-topline assumption for Xero is 72%, or 1 ppt below the company's guidance ... on price in the new geographical region. A study (not available publicly) published by RBC on March ...

Objective: Head and neck cancer (HNC) treatments are known to significantly affect functionality and appearance, leading to an increased risk for body image disturbances. Yet, few longitudinal studies ...